Logo image of VVOS

VIVOS THERAPEUTICS INC (VVOS) Stock Overview

USA - NASDAQ:VVOS - US92859E2072 - Common Stock

3.44 USD
+0.1 (+2.99%)
Last: 9/19/2025, 8:00:02 PM
3.5 USD
+0.06 (+1.74%)
After Hours: 9/19/2025, 8:00:02 PM

VVOS Key Statistics, Chart & Performance

Key Statistics
52 Week High7.95
52 Week Low1.98
Market Cap25.80M
Shares7.50M
Float5.29M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.68
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO12-11 2020-12-11
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


VVOS short term performance overview.The bars show the price performance of VVOS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20

VVOS long term performance overview.The bars show the price performance of VVOS in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of VVOS is 3.44 USD. In the past month the price decreased by -25.22%. In the past year, price increased by 11.69%.

VIVOS THERAPEUTICS INC / VVOS Daily stock chart

VVOS Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.82 95.02B
CI THE CIGNA GROUP 10.34 77.51B
LH LABCORP HOLDINGS INC 18.31 23.04B
DGX QUEST DIAGNOSTICS INC 19.41 20.53B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 127.49 16.71B
FMS FRESENIUS MEDICAL CARE-ADR 12.28 14.85B
HIMS HIMS & HERS HEALTH INC 72.27 13.07B
DVA DAVITA INC 13.43 9.31B
GH GUARDANT HEALTH INC N/A 7.38B
CHE CHEMED CORP 20.22 6.59B
RDNT RADNET INC 212.33 5.88B
BTSG BRIGHTSPRING HEALTH SERVICES 36.91 4.84B

About VVOS

Company Profile

VVOS logo image Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.

Company Info

VIVOS THERAPEUTICS INC

7921 Southpark Plaza,, Suite 210

Littleton COLORADO US

Employees: 109

VVOS Company Website

VVOS Investor Relations

Phone: 18669084867

VIVOS THERAPEUTICS INC / VVOS FAQ

What is the stock price of VIVOS THERAPEUTICS INC today?

The current stock price of VVOS is 3.44 USD. The price increased by 2.99% in the last trading session.


What is the ticker symbol for VIVOS THERAPEUTICS INC stock?

The exchange symbol of VIVOS THERAPEUTICS INC is VVOS and it is listed on the Nasdaq exchange.


On which exchange is VVOS stock listed?

VVOS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for VIVOS THERAPEUTICS INC stock?

8 analysts have analysed VVOS and the average price target is 5.36 USD. This implies a price increase of 55.67% is expected in the next year compared to the current price of 3.44. Check the VIVOS THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VIVOS THERAPEUTICS INC worth?

VIVOS THERAPEUTICS INC (VVOS) has a market capitalization of 25.80M USD. This makes VVOS a Nano Cap stock.


How many employees does VIVOS THERAPEUTICS INC have?

VIVOS THERAPEUTICS INC (VVOS) currently has 109 employees.


What are the support and resistance levels for VIVOS THERAPEUTICS INC (VVOS) stock?

VIVOS THERAPEUTICS INC (VVOS) has a support level at 3.43 and a resistance level at 5.26. Check the full technical report for a detailed analysis of VVOS support and resistance levels.


Is VIVOS THERAPEUTICS INC (VVOS) expected to grow?

The Revenue of VIVOS THERAPEUTICS INC (VVOS) is expected to grow by 12.5% in the next year. Check the estimates tab for more information on the VVOS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VIVOS THERAPEUTICS INC (VVOS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VIVOS THERAPEUTICS INC (VVOS) stock pay dividends?

VVOS does not pay a dividend.


When does VIVOS THERAPEUTICS INC (VVOS) report earnings?

VIVOS THERAPEUTICS INC (VVOS) will report earnings on 2025-11-12.


What is the Price/Earnings (PE) ratio of VIVOS THERAPEUTICS INC (VVOS)?

VIVOS THERAPEUTICS INC (VVOS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.68).


What is the Short Interest ratio of VIVOS THERAPEUTICS INC (VVOS) stock?

The outstanding short interest for VIVOS THERAPEUTICS INC (VVOS) is 3.67% of its float. Check the ownership tab for more information on the VVOS short interest.


VVOS Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to VVOS. When comparing the yearly performance of all stocks, VVOS is one of the better performing stocks in the market, outperforming 74.93% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

VVOS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to VVOS. VVOS has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VVOS Financial Highlights

Over the last trailing twelve months VVOS reported a non-GAAP Earnings per Share(EPS) of -1.68. The EPS increased by 75.65% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -55.01%
ROE -312.46%
Debt/Equity 1.72
Chartmill High Growth Momentum
EPS Q2Q%8.33%
Sales Q2Q%-5.77%
EPS 1Y (TTM)75.65%
Revenue 1Y (TTM)2.66%

VVOS Forecast & Estimates

8 analysts have analysed VVOS and the average price target is 5.36 USD. This implies a price increase of 55.67% is expected in the next year compared to the current price of 3.44.

For the next year, analysts expect an EPS growth of 46.02% and a revenue growth 12.5% for VVOS


Analysts
Analysts80
Price Target5.36 (55.81%)
EPS Next Y46.02%
Revenue Next Year12.5%

VVOS Ownership

Ownership
Inst Owners9.09%
Ins Owners21.93%
Short Float %3.67%
Short Ratio0.73